MSD, Novo Nordisk On Accessing Korea’s Innovative Momentum
This article was originally published in PharmAsia News
Executive Summary
At a recent biotech convention in Seoul, MSD and Novo Nordisk talked were both bullish on accessing innovation in Asia-Pacific, with the US firm in particular stepping up its business development and licensing activities in South Korea to access what it sees as the innovative momentum in the country.